Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Practicing Rheumatology in Dubai

Humeira Badsha, MD  |  Issue: June 2014  |  June 1, 2014

States can operate their own exchanges or defer to the federal Health Care Exchange.
Patients with members of a sponsoring AbbVie team, nurses, doctors, a physiotherapist and a Yoga therapist, for an ankylosing spondyl­itis awareness event.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Humeira Badsha, MD
Humeira Badsha, MD

I planned to stay for only two years. Almost nine years later, I am still practicing rheumatology in Dubai, the United Arab Emirates (UAE). Why did I stay so long? Part of the answer lies in the hopeful look of a recent patient, Abdullah.

Abdullah’s Story

He is 16, like my teenage son. Unlike my son, Abdullah recently escaped horrific conditions in war-torn Damascus, Syria. When I met him, he had not been able to find methotrexate to treat his juvenile arthritis for six months and been unable to locate his rheumatologist for almost a year. Against all odds, his brother managed to get Abdullah a visa so he could visit him in the UAE. They drove two hours just to see me. He had fixed flexion contractures of his fingers, and all of his large joints were swollen, tender and barely moving. The erythrocyte sedimentation rate was 100 mm/hr.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I am saddened this boy does not have to deal with just the usual teenage angst of acne, which parties to attend or which girls to talk to. We started him back on methotrexate and steroids, but this regimen was insufficient, and his family could not afford the cost of biological drugs. Time was running out; his visitor’s visa was valid for just one month.

In 2007, we had founded the Emirates Arthritis Foundation (EAF) to help patients who cannot afford their treatment. This support allowed us to start Abdullah on anti-TNF therapy. Fortunately, he was granted a visa extension on medical grounds. After seven weeks of treatment, his arthritis remitted, and Abdullah experienced a growth spurt of a few inches. The hopeful look in his face turned to one of quiet joy.

When I am bogged down by the mundane, the endless paperwork, the hassles of dealing with health insurance rejections, the patient complaints and the overbooked schedule, I think of the EAF, and how it has made such a difference in the lives of many.

A Study in Contrasts

Dubai surprised me. I thought I was leaving the Boston suburbs to work in an oil-rich Gulf State and would be taking care of wealthy, pampered patients. Instead, I found a city with very little oil reserves that had the breathtaking audacity to want to be like New York, London or Paris. Buildings, financial service institutions, hotels and hospitals were being constructed at a crazy pace. However, the nascent healthcare sector still faced considerable challenges. The private healthcare sector was now being told to assume responsibility for the city’s predominantly expat population, a task that was previously performed by the government. My challenges lay in taking care of patients who could not afford the coverage. Dealing with an illness is one problem, but for a noncitizen resident of the UAE, being diagnosed with a chronic disease almost certainly meant the loss of their job and repatriation to their home country.

Page: 1 2 3 | Single Page
Share: 

Filed under:Axial SpondyloarthritisBiologics/DMARDsConditionsDrug UpdatesLegislation & AdvocacyProfessional TopicsProfiles Tagged with:AdvocacyAnkylosing SpondylitisBiologicsDubaiInternationalMethotrexaterheumatologistSteroids

Related Articles

    Challenges and Joys of Practice in Dubai

    September 1, 2010

    Rheumatology report from another world

    ACR & Emirates Society of Rheumatology Produce Education Conference

    December 17, 2018

    In September, the ACR participated in a global rheumatology event by partnering with the Emirates Society of Rheumatology (ESR) to jointly produce an educational meeting. The 4th Annual Conference of the Emirates Society of Rheumatology, in partnership with the ACR, took place Sept. 19–21 in Dubai Festival City, Dubai, United Arab Emirates (UAE). The conference…

    Old Drugs Can Learn New Tricks

    November 1, 2011

    Methotrexate and its mechanism of action

    Letters: Rheumatologist’s Trip to Rural Nepal Is A Fine Adventure

    December 1, 2013

    Praise for Dr. Steven S. Overman’s expedition medicine trip to Nepal

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences